Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
    October 2017
  1. DIAZ F, Gregory S, Nakashima H, Viapiano MS, et al
    Intramuscular delivery of replication-defective herpes simplex virus gives antigen expression in muscle syncytia and improved protection against pathogenic HSV-2 strains.
    Virology. 2017;513:129-135.
    >> Share

  2. SCHWARTZ EJ, Vaidya NK, Dorman KS, Carpenter S, et al
    Dynamics of lentiviral infection in vivo in the absence of adaptive immune responses.
    Virology. 2017;513:108-113.
    >> Share

  3. MA TC, Le Guo, Zhou RH, Wang X, et al
    Soybean-derived Bowman-Birk inhibitor (BBI) blocks HIV entry into macrophages.
    Virology. 2017;513:91-97.
    >> Share

  4. DUFRASNE FE, Lucchetti M, Martin A, Andre E, et al
    Modulation of the NF-kappaB signaling pathway by the HIV-2 envelope glycoprotein and its incomplete BST-2 antagonism.
    Virology. 2017;513:11-16.
    >> Share

  5. YUE Y, Coskun AK, Jawanda N, Auer J, et al
    Differential interaction between human and murine Crm1 and lentiviral Rev proteins.
    Virology. 2017;513:1-10.
    >> Share

  6. JOSHI A, Cox EK, Sedano MJ, Punke EB, et al
    HIV-1 subtype CRF01_AE and B differ in utilization of low levels of CCR5, Maraviroc susceptibility and potential N-glycosylation sites.
    Virology. 2017;512:222-233.
    >> Share

    September 2017
  7. NAHABEDIAN J, Sharma A, Kaczmarek ME, Wilkerson GK, et al
    Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry.
    Virology. 2017;512:180-186.
    >> Share

  8. JIA M, Shaw T, Zhang X, Liu D, et al
    Decoding noises in HIV computational genotyping.
    Virology. 2017;511:249-255.
    >> Share

    August 2017
  9. MOLAN AM, Hanson HM, Chweya CM, Anderson BD, et al
    APOBEC3B lysine residues are dispensable for DNA cytosine deamination, HIV-1 restriction, and nuclear localization.
    Virology. 2017;511:74-81.
    >> Share

  10. POSTLER TS, Pantry SN, Desrosiers RC, Ghosh S, et al
    Identification and characterization of a long non-coding RNA up-regulated during HIV-1 infection.
    Virology. 2017;511:30-39.
    >> Share

  11. ZHANG N, Guo H, Yang J, Liu G, et al
    The poly-proline tail of SIVmac Vpx provides gain of function for resistance to a cryptic proteasome-dependent degradation pathway.
    Virology. 2017;511:23-29.
    >> Share

    July 2017
  12. VANCOILLIE L, Hebberecht L, Dauwe K, Demecheleer E, et al
    Longitudinal sequencing of HIV-1 infected patients with low-level viremia for years while on ART shows no indications for genetic evolution of the virus.
    Virology. 2017;510:185-193.
    >> Share

  13. SCHMITT K, Mohan Kumar D, Curlin J, Remling-Mulder L, et al
    Modeling the evolution of SIV sooty mangabey progenitor virus towards HIV-2 using humanized mice.
    Virology. 2017;510:175-184.
    >> Share

  14. DESIMIO MG, Giuliani E, Doria M
    The histone deacetylase inhibitor SAHA simultaneously reactivates HIV-1 from latency and up-regulates NKG2D ligands sensitizing for natural killer cell cytotoxicity.
    Virology. 2017;510:9-21.
    >> Share

  15. DAS S, Boliar S, Samal S, Ahmed S, et al
    Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with properties comparable to membrane-bound BG505.
    Virology. 2017;510:22-28.
    >> Share

    June 2017
  16. VAN DEN DRIES L, Claassen MAA, Groothuismink ZMA, van Gorp E, et al
    Immune activation in prolonged cART-suppressed HIV patients is comparable to that of healthy controls.
    Virology. 2017;509:133-139.
    >> Share

  17. TERRY SN, Manganaro L, Cuesta-Dominguez A, Brinzevich D, et al
    Expression of HERV-K108 envelope interferes with HIV-1 production.
    Virology. 2017;509:52-59.
    >> Share

    May 2017
  18. CHAND S, Messina EL, AlSalmi W, Ananthaswamy N, et al
    Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by alpha4beta7 integrin.
    Virology. 2017 May 31. pii: S0042-6822(17)30164.
    >> Share

  19. KIM J, Jobe O, Peachman KK, Michael NL, et al
    Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies.
    Virology. 2017 May 31. pii: S0042-6822(17)30165.
    >> Share

  20. JACOB RA, Johnson AL, Pawlak EN, Dirk BS, et al
    The interaction between HIV-1 Nef and adaptor protein-2 reduces Nef-mediated CD4+ T cell apoptosis.
    Virology. 2017;509:1-10.
    >> Share

  21. BELIAKOVA-BETHELL N, Hezareh M, Wong JK, Strain MC, et al
    Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART.
    Virology. 2017;508:127-133.
    >> Share

  22. ESPY N, Pacheco B, Sodroski J
    Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.
    Virology. 2017;508:90-107.
    >> Share

    April 2017
  23. MEADOR LR, Kessans SA, Kilbourne J, Kibler KV, et al
    A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.
    Virology. 2017;507:242-256.
    >> Share

  24. CHARLINS P, Schmitt K, Remling-Mulder L, Hogan LE, et al
    A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.
    Virology. 2017;507:135-139.
    >> Share

    March 2017
  25. ZAPATA JC, Campilongo F, Barclay RA, DeMarino C, et al
    The Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assembly.
    Virology. 2017;506:34-44.
    >> Share

  26. CROOKS ET, Osawa K, Tong T, Grimley SL, et al
    Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction.
    Virology. 2017;505:193-209.
    >> Share

    February 2017
  27. BANERJEE S, Shi H, Banasik M, Moon H, et al
    Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Virology. 2017;505:113-126.
    >> Share

  28. BONAR MM, Tilton JC
    High sensitivity detection and sorting of infectious human immunodeficiency virus (HIV-1) particles by flow virometry.
    Virology. 2017;505:80-90.
    >> Share

  29. RODGERS MA, Vallari AS, Harris B, Yamaguchi J, et al
    Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon.
    Virology. 2017;504:141-151.
    >> Share

    January 2017
  30. ROBINSON TO, Zhang M, Ochsenbauer C, Smythies LE, et al
    CD4 regulatory T cells augment HIV-1 expression of polarized M1 and M2 monocyte derived macrophages.
    Virology. 2017;504:79-87.
    >> Share

  31. GEDDES VE, Jose DP, Leal FE, Nixon DF, et al
    HTLV-1 Tax activates HIV-1 transcription in latency models.
    Virology. 2017;504:45-51.
    >> Share

  32. FILIPPONE C, de Oliveira F, Betsem E, Schaeffer L, et al
    Simian Immunodeficiency Virus seroreactivity in inhabitants from rural Cameroon frequently in contact with non-human primates.
    Virology. 2017;503:76-82.
    >> Share

  33. MIYAGI E, Kao S, Fumitaka M, Buckler-White A, et al
    Long-term passage of Vif-null HIV-1 in CD4+ T cells expressing sub-lethal levels of APOBEC proteins fails to develop APOBEC resistance.
    Virology. 2017;504:1-11.
    >> Share

  34. ZHAO G, Wu G, Lim ES, Droit L, et al
    VirusSeeker, a computational pipeline for virus discovery and virome composition analysis.
    Virology. 2017;503:21-30.
    >> Share

    December 2016
  35. YUAN Z, Ma F, Demers AJ, Wang D, et al
    Characterization of founder viruses in very early SIV rectal transmission.
    Virology. 2016;502:97-105.
    >> Share

  36. LE SAGE V, Cinti A, McCarthy S, Amorim R, et al
    Ebola virus VP35 blocks stress granule assembly.
    Virology. 2016;502:73-83.
    >> Share

    November 2016
  37. HU S, Neff CP, Kumar DM, Habu Y, et al
    A humanized mouse model for HIV-2 infection and efficacy testing of a single-pill triple-drug combination anti-retroviral therapy.
    Virology. 2016;501:115-118.
    >> Share

  38. VANWALSCAPPEL B, Rato S, Perez-Olmeda M, Diez Fuertes F, et al
    Genetic and phenotypic analyses of sequential vpu alleles from HIV-infected IFN-treated patients.
    Virology. 2016;500:247-258.
    >> Share

  39. MOYO T, Ferreira RC, Davids R, Sonday Z, et al
    Chinks in the armor of the HIV-1 Envelope glycan shield: Implications for immune escape from anti-glycan broadly neutralizing antibodies.
    Virology. 2016;501:12-24.
    >> Share

  40. LAMICHHANE R, Mukherjee S, Smolin N, Pauszek RF 3rd, et al
    Dynamic conformational changes in the rhesus TRIM5alpha dimer dictate the potency of HIV-1 restriction.
    Virology. 2016;500:161-168.
    >> Share

    October 2016
  41. ASMAL M, Lane S, Tian M, Nickel G, et al
    Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections.
    Virology. 2016;499:298-312.
    >> Share

    September 2016
  42. MAKHDOOMI MA, Singh D, Nair Pananghat A, Lodha R, et al
    Neutralization resistant HIV-1 primary isolates from antiretroviral naive chronically infected children in India.
    Virology. 2016;499:105-113.
    >> Share

  43. AGOSTO LM, Hirnet JB, Michaels DH, Shaik-Dasthagirisaheb YB, et al
    Porphyromonas gingivalis-mediated signaling through TLR4 mediates persistent HIV infection of primary macrophages.
    Virology. 2016;499:72-81.
    >> Share

  44. SUGDEN S, Ghazawi F, MacPherson P
    HIV-1 tat protein recruits CIS to the cytoplasmic tail of CD127 to induce receptor ubiquitination and proteasomal degradation.
    Virology. 2016;498:192-200.
    >> Share

    August 2016
  45. WANG Y, Wang Z, Pramanik A, Santiago ML, et al
    A chimeric human APOBEC3A protein with a three amino acid insertion confers differential HIV-1 and adeno-associated virus restriction.
    Virology. 2016;498:149-163.
    >> Share

  46. IMLE A, Stolp B, Bohmer V, Geyer M, et al
    D186/D190 is an allele-dependent determinant of HIV-1 Nef function.
    Virology. 2016;498:44-56.
    >> Share

  47. KIJEWSKI SD, Akiyama H, Feizpour A, Miller CM, et al
    Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated.
    Virology. 2016;497:328-336.
    >> Share

    July 2016
  48. ALEXANDRE KB, Mufhandu HT, London GM, Chakauya E, et al
    Progress and Perspectives on HIV-1 microbicide development.
    Virology. 2016;497:69-80.
    >> Share

  49. SANTOS S, Obukhov Y, Nekhai S, Pushkarsky T, et al
    Cellular minichromosome maintenance complex component 5 (MCM5) is incorporated into HIV-1 virions and modulates viral replication in the newly infected cells.
    Virology. 2016;497:11-22.
    >> Share

    June 2016
  50. ZHANG X, Zhou T, Frabutt DA, Zheng YH, et al
    HIV-1 Vpr increases Env expression by preventing Env from endoplasmic reticulum-associated protein degradation (ERAD).
    Virology. 2016;496:194-202.
    >> Share

  51. KAKISAKA M, Yamada K, Yamaji-Hasegawa A, Kobayashi T, et al
    Intrinsically disordered region of influenza A NP regulates viral genome packaging via interactions with viral RNA and host PI(4,5)P.
    Virology. 2016;496:116-126.
    >> Share

    May 2016
  52. JUNQUEIRA DM, Almeida SE
    HIV-1 subtype B: Traces of a pandemic.
    Virology. 2016;495:173-184.
    >> Share

  53. LIN YZ, Sun LK, Zhu DT, Hu Z, et al
    Equine schlafen 11 restricts the production of equine infectious anemia virus via a codon usage-dependent mechanism.
    Virology. 2016;495:112-121.
    >> Share

  54. BONIFATI S, Daly MB, St Gelais C, Kim SH, et al
    SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cells.
    Virology. 2016;495:92-100.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016